ArticleBMC cancer2020

Genetic diagnostic features after failure of initial treatment with epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors among non-small-cell lung cancer patients harboring EGFR mutations.

Yuichiro Takeda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.